Altimmune, Inc. (ALT) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

Altimmune, Inc. (ALT) closed at 2.60 (-1.14%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -16.67%, with price is trading in the lower part of its roughly 52-week range (2.60–7.71), while ATR14 volatility is elevated at roughly 7.22% of price. RSI(14) is 28.0, reflecting a defensive momentum profile with buyers still struggling to regain control. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Nearby upside pressure sits around 3.31. A decisive move through that level would improve the short-term picture. Latest fundamentals snapshot: Revenue: 5,000 · Net income: -19.01M · EPS (basic): -0.21. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more